Bone Biologics (BBLG) Revenue (2016 - 2017)
Historic Revenue for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to -$1.5 million.
- Bone Biologics' Revenue changed N/A to -$1.5 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$4.4 million, marking a year-over-year decrease of 32855.44%. This contributed to the annual value of -$805109.0 for FY2021, which is 1933.39% up from last year.
- As of Q4 2017, Bone Biologics' Revenue stood at -$1.5 million.
- Over the past 5 years, Bone Biologics' Revenue peaked at -$310089.0 during Q1 2016, and registered a low of -$1.5 million during Q4 2017.